Lantern Pharma (LTRN) Tops Q4 EPS by 16c
Lantern Pharma (NASDAQ: LTRN) reported Q4 EPS of ($0.31), $0.16 better than the analyst estimate of ($0.47).
For earnings history and earnings-related data on Lantern Pharma (LTRN) click here.
Lantern Pharma (NASDAQ: LTRN) reported Q4 EPS of ($0.31), $0.16 better than the analyst estimate of ($0.47).
For earnings history and earnings-related data on Lantern Pharma (LTRN) click here.